Cargando…

Schizophrenia Animal Modeling with Epidermal Growth Factor and Its Homologs: Their Connections to the Inflammatory Pathway and the Dopamine System

Epidermal growth factor (EGF) and its homologs, such as neuregulins, bind to ErbB (Her) receptor kinases and regulate glial differentiation and dopaminergic/GABAergic maturation in the brain and are therefore implicated in schizophrenia neuropathology involving these cell abnormalities. In this revi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sotoyama, Hidekazu, Namba, Hisaaki, Tohmi, Manavu, Nawa, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953688/ https://www.ncbi.nlm.nih.gov/pubmed/36830741 http://dx.doi.org/10.3390/biom13020372

Ejemplares similares

Increased self-triggered vocalizations in an epidermal growth factor-induced rat model for schizophrenia
por: Narihara, Itaru, et al.
Publicado: (2022)

Neonatal exposure to an inflammatory cytokine, epidermal growth factor, results in the deficits of mismatch negativity in rats
por: Jodo, Eiichi, et al.
Publicado: (2019)

Neuropathologic Implication of Peripheral Neuregulin-1 and EGF Signals in Dopaminergic Dysfunction and Behavioral Deficits Relevant to Schizophrenia: Their Target Cells and Time Window
por: Nawa, Hiroyuki, et al.
Publicado: (2014)

Pallidal Hyperdopaminergic Innervation Underlying D2 Receptor-Dependent Behavioral Deficits in the Schizophrenia Animal Model Established by EGF
por: Sotoyama, Hidekazu, et al.
Publicado: (2011)

Resting-state dopaminergic cell firing in the ventral tegmental area negatively regulates affiliative social interactions in a developmental animal model of schizophrenia
por: Sotoyama, Hidekazu, et al.
Publicado: (2021)

ErbB inhibitors ameliorate behavioral impairments of an animal model for schizophrenia: implication of their dopamine-modulatory actions
por: Mizuno, M, et al.
Publicado: (2013)

Sound frequency dependence of duration mismatch negativity recorded from awake rats
por: Inaba, Hiroyoshi, et al.
Publicado: (2019)

Inter‐breeder differences in prepulse inhibition deficits of C57BL/6J mice in a maternal immune activation model
por: Kobayashi, Yutaro, et al.
Publicado: (2021)

Rapid development of motion-streak coding in the mouse visual cortex
por: Tohmi, Manavu, et al.
Publicado: (2022)

Perinatal Exposure to Neuregulin-1 Results in Disinhibition of Adult Midbrain Dopaminergic Neurons: Implication in Schizophrenia Modeling
por: Namba, Hisaaki, et al.
Publicado: (2016)

The dopamine D2 agonist quinpirole impairs frontal mismatch responses to sound frequency deviations in freely moving rats
por: Inaba, Hiroyoshi, et al.
Publicado: (2021)

Clozapine-dependent inhibition of EGF/neuregulin receptor (ErbB) kinases
por: Kobayashi, Yutaro, et al.
Publicado: (2019)

Advanced glycation end products induce brain-derived neurotrophic factor release from human platelets through the Src-family kinase activation
por: Furukawa, Kazuo, et al.
Publicado: (2017)

Auditory Cortical Areas Activated by Slow Frequency-Modulated Sounds in Mice
por: Honma, Yuusuke, et al.
Publicado: (2013)

Enhanced Dopamine in Prodromal Schizophrenia (EDiPS): a new animal model of relevance to schizophrenia
por: Petty, Alice, et al.
Publicado: (2019)

Increasing dopamine synthesis in nigrostriatal circuits increases phasic dopamine release and alters dorsal striatal connectivity: implications for schizophrenia
por: Srivastav, Sunil, et al.
Publicado: (2023)

Cerebrocortical activation following unilateral labyrinthectomy in mice characterized by whole-brain clearing: implications for sensory reweighting
por: Kai, Ryota, et al.
Publicado: (2022)

S156. FRONTO-STRIATAL FUNCTIONAL CONNECTIVITY AND STRIATAL DOPAMINE CAPACITY IN TREATMENT-RESPONSIVE AND REFRACTORY SCHIZOPHRENIA
por: Kim, Seoyoung, et al.
Publicado: (2018)

Dopamine supersensitivity psychosis and dopamine partial agonist: A retrospective survey of failure of switching to aripiprazole in schizophrenia
por: Takase, Masayuki, et al.
Publicado: (2015)

Assessment of epidermal growth factor receptor status in glioblastomas
por: Zhu, Hui-Jun, et al.
Publicado: (2013)

Orthovanadate-induced vasocontraction is mediated by the activation of Rho-kinase through Src-dependent transactivation of epidermal growth factor receptor
por: Yayama, Katsutoshi, et al.
Publicado: (2014)

CENTRAL DOPAMINE AND SEROTONIN TURNOVER IN SCHIZOPHRENIA
por: Pandey, R.S., et al.
Publicado: (1987)

Abnormal Striatal Dopamine Transmission in Schizophrenia
por: Brunelin, Jerome, et al.
Publicado: (2013)

A challenge to the dopamine orthodoxy in schizophrenia?
por: Norman, Trevor R, et al.
Publicado: (2023)

ErbB1-4-dependent EGF/neuregulin signals and their cross talk in the central nervous system: pathological implications in schizophrenia and Parkinson's disease
por: Iwakura, Yuriko, et al.
Publicado: (2013)

New Genetic Findings in Schizophrenia: Is there Still Room for the Dopamine Hypothesis of Schizophrenia?
por: Nieratschker, Vanessa, et al.
Publicado: (2010)

Striatal dopamine, reward, and decision making in schizophrenia
por: Deserno, Lorenz, et al.
Publicado: (2016)

Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms
por: McCutcheon, Robert A., et al.
Publicado: (2019)

Dysregulation of Midbrain Dopamine System and the Pathophysiology of Schizophrenia
por: Sonnenschein, Susan F., et al.
Publicado: (2020)

The role of dopamine receptors in lymphocytes and their changes in schizophrenia
por: Penedo, M.A., et al.
Publicado: (2021)

Low status, humiliation, dopamine and risk of schizophrenia
por: Selten, Jean Paul, et al.
Publicado: (2023)

Epidermal Growth Factor Attenuated the Expression of Inflammatory Cytokines in Human Epidermal Keratinocyte Exposed to Propionibacterium acnes
por: Kim, Ji Min, et al.
Publicado: (2018)

Serum Epidermal Growth Factor is Low in Schizophrenia and Not Affected by Antipsychotics Alone or Combined With Electroconvulsive Therapy
por: Zhang, Xiaobin, et al.
Publicado: (2020)

New approaches to the management of schizophrenia: focus on aberrant hippocampal drive of dopamine pathways
por: Perez, Stephanie M, et al.
Publicado: (2014)

Dopamine–prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidity
por: Gragnoli, C, et al.
Publicado: (2016)

Gene-sex interactions in schizophrenia: focus on dopamine neurotransmission
por: Godar, Sean C., et al.
Publicado: (2014)

Eluding the illusion? Schizophrenia, dopamine and the McGurk effect
por: White, Thomas P., et al.
Publicado: (2014)

Striatal Dopamine Release in Schizophrenia Comorbid with Substance Dependence
por: Thompson, Judy L., et al.
Publicado: (2012)

Serotonin and dopamine receptors in motivational and cognitive disturbances of schizophrenia
por: Sumiyoshi, Tomiki, et al.
Publicado: (2014)

New Targets for Schizophrenia Treatment beyond the Dopamine Hypothesis
por: Yang, Albert C., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gj2mklj1l2tkpd7imleidlql86